Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-700-2 | CAS number: 66455-29-6
Toxicological information
Skin sensitisation
Currently viewing:
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 974
- Report date:
- 1974
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: J.H. Draize in the F. & D.A. handbook, Appraisal of the Safety of Chemicals in Food, Drugs and Cosmetics (1959)
- Deviations:
- not applicable
- Remarks:
- Test was performed before actual guideline was established
- Principles of method if other than guideline:
- Test was performed before actual guideline was established.
- GLP compliance:
- no
- Type of study:
- Draize test
- Justification for non-LLNA method:
- Historical in vivo data available
Test material
- Reference substance name:
- Betaines, C12-14 (even numbered)-alkyldimethyl
- EC Number:
- 931-700-2
- Cas Number:
- 66455-29-6
- Molecular formula:
- C16H33NO2 C18H37NO2
- IUPAC Name:
- Betaines, C12-14 (even numbered)-alkyldimethyl
- Test material form:
- other: aqueous formulation
- Details on test material:
- - Name of test material (as cited in study report): Alkyl dimethyl betaine solutions B/8535 and B/8536
- Physical state: liquid
- Analytical purity: 30 % active ingredient
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 300-500 g
- Diet: ad libitum
- Water: ad libitum
ENVIRONMENTAL CONDITIONS
- Temperature (°C): thermostatically controlled, not further specified
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 0.1 % active ingredient
Challengeopen allclose all
- Route:
- intradermal
- Vehicle:
- physiological saline
- Concentration / amount:
- 0.1 % active ingredient
- No. of animals per dose:
- 6
- Details on study design:
- MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 10 (1x0.05 ml; 9x0.1 ml)
- Test groups: Test substance in saline
- Site: back, not further specified
- Frequency of applications: every 2 days
- Duration: 0-18 days
- Concentrations: 0.1 % active ingredient
B. CHALLENGE EXPOSURE
- No. of exposures: 1 (0.05 ml)
- Day(s) of challenge: 32
- Test groups: Test substance
- Site: back, not further specified
- Concentrations: 0.1 % active ingredient
- Evaluation (hr after challenge): 4 and 24
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 4
- Group:
- test chemical
- Dose level:
- 0.1 % active ingredient
- No. with + reactions:
- 0
- Total no. in group:
- 6
- Clinical observations:
- Injection site pink with white centre, 7.0 mm mean diameter, 1.0 mm mean height.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 4.0. Group: test group. Dose level: 0.1 % active ingredient. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: Injection site pink with white centre, 7.0 mm mean diameter, 1.0 mm mean height..
- Reading:
- 2nd reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 0.1 % active ingredient
- No. with + reactions:
- 0
- Total no. in group:
- 6
- Clinical observations:
- Injection site pink with white centre, 9.0 mm mean diameter, 1.0 mm mean height; the reaction produced by the final challenge did not appear to be any greater in diameter, height or colour than the reaction produced by any of the previous injections.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 2nd reading. . Hours after challenge: 24.0. Group: test group. Dose level: 0.1 % active ingredient. No with. + reactions: 0.0. Total no. in groups: 6.0. Clinical observations: Injection site pink with white centre, 9.0 mm mean diameter, 1.0 mm mean height; the reaction produced by the final challenge did not appear to be any greater in diameter, height or colour than the reaction produced by any of the previous injections..
- Group:
- negative control
- Remarks on result:
- not measured/tested
- Group:
- positive control
- Remarks on result:
- not measured/tested
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
